Navigating the Complex Landscape of Oncology Trials

Tailored Solutions for the Unique Challenges of Oncology Trials

Engagement with a range of experts is essential when designing oncology trials, where the complexity of trial design surpasses the expertise of any single individual.

In the latest Pharma’s Almanac article, Colin Hayward, MB BS, Head of Medical Science for Ergomed Clinical Research provides insights into critical components of effective oncology trial design.

Key highlights:

  • Engagement with advocacy groups for patient-centered insights
  • Effective collaboration between study sponsors and seasoned CROs
  • Careful selection of investigator sites
  • Ergomed’s distinctive advantages in advancing oncology trials

Unlock these insights in, “Navigating the Complex Landscape of Oncology Trials.”

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.